Yifeng Pharmacy (603939) — Net Asset Momentum
Yifeng Pharmacy (603939) recorded a net asset momentum of 9.1% as of December 2024, with net assets of CN¥11.39 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Yifeng Pharmacy defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Yifeng Pharmacy Net Asset Momentum (2011–2024)
This chart tracks Yifeng Pharmacy's year-over-year net asset growth across 14 annual reporting periods from 2011 to 2024. The most recent momentum reading is +9.1%, with net assets of CN¥11.39 Billion CNY as of December 2024. Read 603939 liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Net Asset History for Yifeng Pharmacy (2011–2024)
The table below shows the complete annual net asset history for Yifeng Pharmacy from 2011 to 2024, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 603939 market cap overview.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥11.39 Billion | CN¥27.97 Billion | CN¥16.58 Billion | ▲ +9.1% |
| 2023 | CN¥10.45 Billion | CN¥24.14 Billion | CN¥13.69 Billion | ▲ +14.5% |
| 2022 | CN¥9.12 Billion | CN¥21.04 Billion | CN¥11.92 Billion | ▲ +16.0% |
| 2021 | CN¥7.86 Billion | CN¥17.05 Billion | CN¥9.19 Billion | ▲ +36.0% |
| 2020 | CN¥5.78 Billion | CN¥12.95 Billion | CN¥7.17 Billion | ▲ +22.8% |
| 2019 | CN¥4.71 Billion | CN¥9.18 Billion | CN¥4.47 Billion | ▲ +12.9% |
| 2018 | CN¥4.17 Billion | CN¥7.87 Billion | CN¥3.70 Billion | ▲ +31.1% |
| 2017 | CN¥3.18 Billion | CN¥4.78 Billion | CN¥1.60 Billion | ▲ +6.9% |
| 2016 | CN¥2.98 Billion | CN¥4.22 Billion | CN¥1.25 Billion | ▲ +109.6% |
| 2015 | CN¥1.42 Billion | CN¥2.44 Billion | CN¥1.02 Billion | ▲ +138.2% |
| 2014 | CN¥595.76 Million | CN¥1.25 Billion | CN¥655.19 Million | ▲ +18.6% |
| 2013 | CN¥502.20 Million | CN¥1.03 Billion | CN¥524.21 Million | ▲ +17.9% |
| 2012 | CN¥425.82 Million | CN¥845.45 Million | CN¥419.63 Million | ▲ +19.5% |
| 2011 | CN¥356.28 Million | CN¥843.41 Million | CN¥487.12 Million | — |